Next-generation nanoparticles for cancer and autoimmune therapy

Next-generation nanoparticles for cancer and autoimmune therapy

<p>Immune modulation is a critical therapeutic approach for cancer and autoimmune diseases, aiming to balance immune activation and suppression within specific disease environments. Next-generation nanoparticles (NPs) offer a promising method for precisely delivering cytokines and other immune...

Full description

Saved in:

Bibliographic Details
Main Author:	Alshayma N. Al-Thani (17976380) (author)
Other Authors:	Asma Ghafoor Jan (19736878) (author), Zainab Hajialthakar (22254328) (author), Ahmed Awad (6052524) (author), Mohamed Abbas (834428) (author)
Published:	2025
Subjects:	Biomedical and clinical sciences Immunology Oncology and carcinogenesis Engineering Biomedical engineering Nanotechnology Nanoparticles (NPs) Immune modulation Cytokines immune checkpoint inhibitors (ICIs) Immune therapy Autoimmune disease Cancer
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Circulating exosomal immuno-oncological checkpoints and cytokines are potential biomarkers to monitor tumor response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients
by: Shayista Akbar (14442117)
Published: (2023)

The potential role of vitamin C in empowering cancer immunotherapy
by: Takwa, Bedhiafi
Published: (2022)

Immunomodulatory effects of tumor Lactate Dehydrogenase C (LDHC) in breast cancer
by: Adviti Naik (673163)
Published: (2025)

Molecular profiling of the metaplastic spindle cell carcinoma of the breast reveals potentially targetable biomarkers
by: Semir, Vranic
Published: (2020)

Blockade of PD-1, PD-L1, and TIM-3 Altered Distinct Immune- and Cancer-Related Signaling Pathways in the Transcriptome of Human Breast Cancer Explants
by: Reem Saleh (3513056)
Published: (2020)

Role of HMGB1 and its associated signaling pathways in human malignancies
by: Sourour, Idoudi
Published: (2023)

Editorial: Dynamic Biomarkers of Response to Anti-Immune Checkpoint Inhibitors in Cancer
by: Said Dermime (79420)
Published: (2021)

Dynamic Biomarkers of Response to Anti-Immune Checkpoint Inhibitors in Cancer
by: Said Dermime (79420)
Published: (2021)

The complex network of transcription factors, immune checkpoint inhibitors and stemness features in colorectal cancer: A recent update
by: Maysaloun Merhi (4246147)
Published: (2023)

Immune checkpoint inhibitors: recent progress and potential biomarkers
by: Pramod Darvin (153341)
Published: (2018)

Emerging dynamics pathways of response and resistance to PD-1 and CTLA-4 blockade: tackling uncertainty by confronting complexity
by: Allan Relecom (14153295)
Published: (2021)

Immune-related 3-lncRNA signature with prognostic connotation in a multi-cancer setting
by: Shimaa Sherif (12862990)
Published: (2022)

In search of immune cellular sources of abnormal cytokines in the blood in autism spectrum disorder: A systematic review of case-control studies
by: Wared Nour-Eldine (13904298)
Published: (2022)

NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives
by: Remy Thomas (702843)
Published: (2018)

The potential role of vitamin C in empowering cancer immunotherapy
by: Takwa Bedhiafi (14153460)
Published: (2022)

Immune Checkpoints in Circulating and Tumor-Infiltrating CD4+ T Cell Subsets in Colorectal Cancer Patients
by: Salman M. Toor (8854751)
Published: (2019)

Exosome nanovesicles as potential biomarkers and immune checkpoint signaling modulators in lung cancer microenvironment: recent advances and emerging concepts
by: Naushad Ahmad Khan (6406973)
Published: (2023)

Extent and Mitigation of Financial Toxicity of Immune Checkpoint Inhibitors for the Treatment of Advanced Hepatocellular Carcinoma
by: Nabil E. Omar (9545756)
Published: (2025)

Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy
by: Ajaz A. Bhat (12984701)
Published: (2021)

Zirconium oxide nanoparticles in advancing photodynamic therapy for cancer treatment
by: Alshayma N. Al-Thani (17976380)
Published: (2025)

Unleashing the immune response to NY-ESO-1 cancer testis antigen as a potential target for cancer immunotherapy
by: Afsheen Raza (492657)
Published: (2022)

Circulating and Tumor-Infiltrating Immune Checkpoint-Expressing CD8+ Treg/T Cell Subsets and Their Associations with Disease-Free Survival in Colorectal Cancer Patients
by: Alhasan Alsalman (14802873)
Published: (2022)

DNA methylation and repressive H3K9 and H3K27 trimethylation in the promoter regions of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, and PD-L1 genes in human primary breast cancer
by: Varun Sasidharan Nair (5396393)
Published: (2018)

Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer
by: Reem Saleh (3513056)
Published: (2020)

Primary immunodeficiency and the microbiome
by: Maryam Ali Al-Nesf (16328649)
Published: (2021)

Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4+ T Cells
by: Reem Saleh (3513056)
Published: (2019)

Role of HMGB1 and its associated signaling pathways in human malignancies
by: Sourour Idoudi (14153457)
Published: (2023)

The microbiome-lymphoma Axis: A systematic review and Meta-analysis of gut Dysbiosis pattern in diffuse large B-cell lymphoma
by: Sarah A. Elkourashy (21632903)
Published: (2025)

T-Regulatory Cells in Health and Disease
by: Eyad Elkord (5396390)
Published: (2018)

Breast Cancer Cells and PD-1/PD-L1 Blockade Upregulate the Expression of PD-1, CTLA-4, TIM-3 and LAG-3 Immune Checkpoints in CD4+ T Cells
by: Reem Saleh (3513056)
Published: (2019)

Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment
by: Azharuddin Sajid Syed Khaja (19720105)
Published: (2017)

<i>In silico </i>formulation of a next-generation multiepitope vaccine for use as a prophylactic candidate against Crimean-Congo hemorrhagic fever
by: Rahat Alam (9286527)
Published: (2023)

DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancer
by: Varun Sasidharan Nair (5396393)
Published: (2018)

Tumor-Infiltrating Lymphoid Cells in Colorectal Cancer Patients with Varying Disease Stages and Microsatellite Instability-High/Stable Tumors
by: Salman M. Toor (8854751)
Published: (2021)

Intratumoral FoxP3<sup>+</sup>Helios<sup>+</sup> Regulatory T Cells Upregulating Immunosuppressive Molecules Are Expanded in Human Colorectal Cancer
by: Azharuddin Sajid Syed Khaja (19720114)
Published: (2017)

BNT162b2 Versus mRNA‐1273 Vaccines: Comparative Analysis of Long‐Term Protection Against SARS‐CoV‐2 Infection and Severe COVID‐19 in Qatar
by: Hiam Chemaitelly (439114)
Published: (2024)

Comparative efficacy and safety of PD-1/PD-L1 inhibitors in triple negative breast cancer: a systematic review and network meta-analysis of randomized controlled trials
by: Ibrahim Elmakaty (14614270)
Published: (2023)

Comparative analysis of within-host diversity among vaccinated COVID-19 patients infected with different SARS-CoV-2 variants
by: Hebah A., Al-Khatib
Published: (2022)

Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) meeting, virtual gathering, 10–13 September 2024
by: Lambach, Philipp
Published: (2025)

Immunity of Arbitrators
by: HARED, ABDIQANI MOHAMED
Published: (2021)